| Realtime | Geld | Brief | Zeit |
|---|---|---|---|
| 1,200 | 1,250 | 09:00 |
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 14.02. | Applied DNA signals growth with GMP facility launch and LineaRx focus in 2025 | ||
| 13.02. | Applied DNA Sciences, Inc.: Applied DNA Reports First Quarter Fiscal 2025 Financial Results and Highlights Operational Progress | - Announces Exit of DNA Tagging and Security Products and Services Business Segment -- Workforce Reduction of 20% of Headcount Implemented in January -- GMP Site 1 Facility Complete and Certified for... ► Artikel lesen | |
| 13.02. | APPLIED DNA SCIENCES INC - 10-Q, Quarterly Report | ||
| 13.02. | APPLIED DNA SCIENCES INC - 8-K, Current Report | ||
| 12.02. | Applied DNA Sciences, Inc.: Applied DNA to Report First Quarter Fiscal 2025 Financial Results After Market Close on Thursday, February 13, 2025 | Investor Call and Webcast Scheduled for 4:30 P.M ET STONY BROOK, NY / ACCESS Newswire / February 12, 2025 / Applied DNA Sciences, Inc. (NASDAQ:APDN) ("Applied DNA" or the "Company"), a leader in polymerase... ► Artikel lesen |
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| Fr | Clinical Laserthermia Systems AB: Clinical Laserthermia Systems AB publishes Year-end report January - December 2024 | Summary of the year-end report (relates to the Group)Full year (01/01/2024-12/31/2024)
Net sales totaled SEK 18,783,000 (SEK 8,273,000).
Operating profit/loss totaled SEK -54,254,000 (SEK -65,933... ► Artikel lesen | |
| 07.02. | Clinical Laserthermia Systems AB: CLS co-founder and former CEO Lars-Erik Eriksson leaves the board of directors at his own request | Lund, Sweden - Clinical Laserthermia Systems AB (publ) ("CLS" or the "Company") today announces that Lars-Erik Eriksson, co-founder, long-time board member and former CEO, is leaving the board of directors... ► Artikel lesen | |
| 30.01. | Clinical Laserthermia Systems AB: Data from the clinical trial using MRI-guided FLA with TRANBERG® Thermal Therapy System in patients with prostate cancer at Radboud University Medical Center (Nijmegen, NL) is now published | ||
| 14.01. | Clinical Laserthermia Systems AB: CLS Recaps 2024 and Provides Outlook for 2025-26 | Lund, Sweden - Clinical Laserthermia Systems AB (publ) ("CLS" or the "Company") today announces that, in its recap of 2024, in the first nine months of 2024 compared to the same period 2023, CLS saw... ► Artikel lesen | |
| 09.12.24 | Clinical Laserthermia Systems AB: The Nomination Committee of Clinical Laserthermia Systems AB has been appointed in accordance with the guidelines for the Nomination Committee adopted at the Annual General Meeting on June 28, 2024. |
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 11.02. | First Andes Silver Ltd: First Andes appoints Stalker chairman, Hutton adviser | ||
| 10.02. | First Andes Silver Ltd.: First Andes Silver Appoints Ian Stalker as Executive Chairman and Director, James Hutton as Advisor and Announces Private Placement Financing of $1,000,000 | Vancouver, British Columbia--(Newsfile Corp. - February 10, 2025) - FIRST ANDES SILVER LTD. (TSXV: FAS) (OTC Pink: MSLVF) (FSE: 9TZ0) (the "Company" or "First Andes") is pleased to announce that seasoned... ► Artikel lesen | |
| 28.01. | First Andes Silver Ltd: First Andes Silver appoints Smith as CEO, director | ||
| 31.12.24 | First Andes Silver Ltd: First Andes Silver terminates offering, CEO resigns | ||
| 06.11.24 | First Andes Silver Ltd: First Andes Silver arranges $1-million financing |
| Unternehmen / Aktien | Kurs | % |
|---|---|---|
| APPLIED DNA SCIENCES INC | 0,170 | 0,00 % |
| CLINICAL LASERTHERMIA SYSTEMS AB | 0,268 | -4,96 % |
| FIRST ANDES SILVER LTD | 0,054 | 0,00 % |
